Sorry, your browser is out of date. To view this page correctly, please install a modern browser (Microsoft Edge, Firefox or Google Chrome).
SAI - Detailed view
Please log in as a company employee using your SIMIS-Login. For further information please see the FAQ.
ANDEMBRY Inj Lös 200 mg 1 Stk
Drug
Andembry, Injektionslösung im Fertigpen
Langzeitprophylaxe wiederkehrender akuter Schübe des hereditären Angioödems (HAE) bei erwachsenen und pädiatrischen Patienten ab 12 Jahren.
02.99.0. – various
HAM – Human medicine
INLFP – Solution for injection in pre-filled pen
BT – biological medicines
B – Dispensed on prescription by a physician or veterinarian (B)
Z – approved
2/24/2025
2/23/2030
Dosage strength
Andembry 200 mg, Injektionslösung im Fertigpen
Langzeitprophylaxe wiederkehrender akuter Schübe des hereditären Angioödems (HAE) bei erwachsenen und pädiatrischen Patienten ab 12 Jahren.
01
Z – approved
Package
7680695530018
In trade (7/1/2025 - 1/1/2040)
A/R – Authorised / referenced
1
001
Z – approved
Declaration
Component
200 mg garadacimabum
histidinum
arginini hydrochloridum
prolinum
polysorbatum 80
aqua ad iniectabile
arginini hydrochloridum
prolinum
polysorbatum 80
aqua ad iniectabile
Authorisation holder
7601001358294
CSL Behring AG
Wankdorfstrasse 10
3014 Bern (BE)
Wankdorfstrasse 10
3014 Bern (BE)
Date of revision of the text
7/9/2025
Please log in as a company employee using your SIMIS-Login. For further information please see the FAQ.
Data source: Swissmedic, *authorisation holder, **Refdata foundation, ***FOPH.